Roflumilast 250 ug/1 (Roflumilast TABLET) 250 ug/1

Roflumilast 250 ug tablets are a pharmaceutical product used for managing respiratory conditions. This oral medication is designed to help improve breathing and reduce inflammation in the lungs.

Strength

250 ug/1

Pack Size

1 BLISTER PACK in 1 CARTON (31722-676-36) / 28 TABLET in 1 BLISTER PACK (31722-676-35)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Roflumilast is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the lungs, which can help improve breathing and reduce symptoms such as wheezing and shortness of breath. Roflumilast tablets are often prescribed for long-term management of COPD, particularly in patients who experience frequent exacerbations.

Side Effects

Common effects of Roflumilast may include headache, diarrhea, nausea, and weight loss. Some users may also experience insomnia or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

Roflumilast should be used with caution in patients with a history of mental health conditions, as it may increase the risk of mood changes. It is also important to inform your healthcare provider about any other medications you are taking, as Roflumilast may interact with certain drugs. Always follow the prescribed dosage and administration instructions provided by your healthcare provider.

Avoid Interactions

Roflumilast may interact with other medications, including those metabolized by the liver enzyme CYP3A4. It is important to avoid taking Roflumilast with strong CYP3A4 inducers or inhibitors, as this can affect the effectiveness of the medication. Additionally, alcohol should be avoided while taking Roflumilast, as it may increase the risk of side effects.

Frequently Asked Questions

Roflumilast is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to reduce inflammation and improve breathing.

Roflumilast tablets are taken orally, typically once daily. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include headache, diarrhea, nausea, weight loss, insomnia, and dizziness.

Roflumilast may interact with certain medications, particularly those metabolized by the liver enzyme CYP3A4. Consult your healthcare provider before combining with other drugs.

Roflumilast is designed for long-term use in the management of COPD. However, regular follow-ups with a healthcare provider are recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.